Newron Pharmaceuticals
NWRN.SW
#8213
Rank
S$0.22 B
Marketcap
$11.51
Share price
2.15%
Change (1 day)
54.57%
Change (1 year)

Earnings for Newron Pharmaceuticals (NWRN.SW)

Earnings in 2023: -S$24.07 Million

According to Newron Pharmaceuticals's latest financial reports the company's current earnings are S$10.01 Million. In 2023 the company made an earning of -S$24.07 Million, an increase over its 2022 earnings that were of -S$25.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Newron Pharmaceuticals from 2005 to 2023

Annual earnings

Year Earnings Change
2023-S$24.07 Million-4.45%
2022-S$25.19 Million11.19%
2021-S$22.65 Million-30.14%
2020-S$32.43 Million6.84%
2019-S$30.35 Million31.45%
2018-S$23.09 Million170.13%
2017-S$8.55 Million-60.23%
2016-S$21.49 Million-41.46%
2015-S$36.71 Million109.46%
2014-S$17.53 Million22.43%
2013-S$14.32 Million222.49%
2012-S$4.44 Million-60.49%
2011-S$11.24 Million-71%
2010-S$38.74 Million-17.37%
2009-S$46.88 Million52.58%
2008-S$30.73 Million41.24%
2007-S$21.76 Million-25.19%
2006-S$29.08 Million22.45%
2005-S$23.75 Million